Pivotal bioVenture Partners Investment Advisor LLC
Venture CapitalPosition in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1844645
SAN FRANCISCO, CA
Position in RXRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,828,240
-$607,428 QoQ
Shares Held
595,518
0.0% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Pivotal bioVenture Partners Investment Advisor LLC holds $268,178,415 across 11 Biotechnology names. RXRX ranks #11 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
|
1,372,425 | $79,751,616 | |
| 2 | OCS |
Oculis Holding AG
|
1,680,283 | $44,678,724 | |
| 3 | EVMN |
Evommune, Inc.
|
1,926,943 | $44,300,419 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,355,892 | $31,944,815 | |
| 5 | TRVI |
Trevi Therapeutics, Inc.
|
1,553,726 | $18,535,951 | |
| 6 | IMNM |
Immunome Inc.
|
732,512 | $16,020,037 | |
| 7 | MPLT |
MapLight Therapeutics, Inc.
|
611,447 | $12,430,717 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
591,991 | $11,573,424 |
All Filings in RXRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,828,240 | 595,518 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,435,668 | 595,518 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,906,127 | 595,518 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,013,321 | 595,518 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,150,290 | 595,518 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $4,025,701 | 595,518 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||